Unternehmen Integrity Applications, Inc. Other OTC
Aktien
IGAP
US45824Q1013
IGAP
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Paul Goode
CEO | Chief Executive Officer | 56 | 17.12.20 |
James Cardwell
DFI | Director of Finance/CFO | 64 | 11.10.23 |
David Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
James Thrower
CTO | Chief Tech/Sci/R&D Officer | 54 | 01.12.21 |
Drinda Benjamin
SAM | Sales & Marketing | 48 | 28.07.23 |
Mark Tapsak
PRN | Corporate Officer/Principal | 55 | 01.09.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Drew Sycoff
BRD | Director/Board Member | 57 | 08.07.19 |
Luis J. Malavé
CHM | Chairman | 61 | 13.02. |
Director/Board Member | 95 | 01.01.10 | |
Allen Danzig
BRD | Director/Board Member | 68 | 31.10.19 |
Paul Goode
CEO | Chief Executive Officer | 56 | 17.12.20 |
Shimon Rapps
BRD | Director/Board Member | 44 | 30.07.19 |
Erin Carter
BRD | Director/Board Member | 54 | 25.08.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 26 756 369 | 17 459 295 ( 65,25 %) | 0 | 65,25 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+1,51 % | 42,75 Mrd. | |
+49,22 % | 41,61 Mrd. | |
+8,57 % | 41,34 Mrd. | |
-12,36 % | 26,59 Mrd. | |
+8,92 % | 25,49 Mrd. | |
-25,13 % | 18,12 Mrd. | |
+29,17 % | 12,24 Mrd. | |
-3,12 % | 11,76 Mrd. | |
+6,35 % | 11 Mrd. |